Alpha Peptides® is preparing the first release in a four-wave expansion of its UK research catalogue. Wave One brings together 12 incoming research materials across neurobiology, cellular signalling, tissue-response, metabolic and peptide-bioregulator research.
The first shipment is expected within the coming week. These products are not yet available to order: each listing will remain unavailable until the stock has physically arrived, its presentation and catalogue information have been checked, and the relevant supporting information has been added.
Preview the full Coming Soon catalogue →
Wave One: 12 incoming research materials
- 5-Amino-1MQ 50mg
- ARA-290 10mg
- Cartalax 20mg
- Cortagen 20mg
- Kisspeptin-10 5mg
- KPV 10mg
- LL-37 5mg
- PE-22-28 10mg
- Pinealon 10mg
- P-21 10mg
- Sermorelin 5mg
- VIP 5mg
This is the first stage rather than the complete expansion. Further specialist compounds and peptide bioregulators will follow through Waves Two, Three and Four as they become ready.
Why Alpha is releasing the range in waves
A long list creates noise. A structured release makes it possible to give each research area the space and context it needs.
Before an incoming product becomes available, Alpha checks the physical stock, final presentation, product information and inventory position. Supporting analytical documentation is published where it is available for the relevant product or batch; its availability can vary and is never implied across the entire catalogue.
The four-wave structure also allows the Research Library to expand alongside the catalogue. Instead of publishing a collection of thin, repetitive product summaries, Alpha will add connected research guides that explain the terminology, distinctions and scientific context around each group.
Neurobiology and neurotrophic-pathway research
Pinealon 10mg
Pinealon is a short synthetic tripeptide associated with the field of peptide bioregulation. Within the Alpha catalogue, it will sit alongside research materials concerned with neuroendocrine and cellular-regulation pathways.
P-21 10mg
P-21, also written as P021 in parts of the research literature, is an experimental synthetic peptidomimetic associated with neurotrophic-pathway research. Its arrival expands the more specialist side of Alpha’s cognitive research range.
PE-22-28 10mg
PE-22-28 is an experimental peptide associated with the spadin research pathway and preclinical investigation of TREK-1-related signalling. It is distinct from P-21 despite both appearing within neurobiological research discussions—an important difference that a forthcoming Alpha guide will examine properly.
Cellular and neuroendocrine signalling
VIP 5mg
Vasoactive intestinal peptide, usually shortened to VIP, is a naturally occurring 28-amino-acid neuropeptide associated with VPAC-receptor signalling. Its research context extends beyond its name, spanning neural, cellular and physiological signalling models.
Kisspeptin-10 5mg
Kisspeptin-10 is the biologically active C-terminal decapeptide of the kisspeptin family. It is studied in laboratory models concerned with KISS1-receptor and neuroendocrine signalling.
Sermorelin 5mg
Sermorelin corresponds to the biologically active GHRH(1–29) sequence and is used in research concerned with growth-hormone-releasing-hormone receptor pathways. It will join Alpha’s established Growth Hormone Research collection as a distinct research material—not as a replacement name for CJC-1295 or Tesamorelin.
Immune-signalling and tissue-response research
KPV 10mg
KPV is the tripeptide Lys-Pro-Val, derived from the alpha-melanocyte-stimulating-hormone sequence. It is discussed in preclinical research involving inflammatory and cellular-response pathways.
LL-37 5mg
LL-37 is a human cathelicidin peptide widely investigated in laboratory research concerning innate immune signalling, microbial interaction and cellular-response models. Alpha’s forthcoming overview will separate established molecular context from claims that extend beyond the evidence.
ARA-290 10mg
ARA-290, also known as cibinetide in published research, is an engineered peptide derived from a region of erythropoietin. It is associated with investigations into tissue-response and innate-repair-receptor pathways.
Metabolic research and peptide bioregulation
5-Amino-1MQ 50mg
Despite often appearing beside peptides in specialist research catalogues, 5-Amino-1MQ is a small-molecule research compound rather than a peptide in the strict biochemical sense. It is studied as an inhibitor of nicotinamide N-methyltransferase, commonly abbreviated to NNMT. Alpha will keep that distinction clear rather than using “peptide” as a blanket label.
Cartalax 20mg
Cartalax is a short peptide bioregulator associated with experimental research involving cartilage-tissue and cellular-regulation models. It forms part of the specialist bioregulator expansion planned across the four release waves.
Cortagen 20mg
Cortagen is another short peptide bioregulator, associated with experimental work concerning neural-tissue and cellular-regulation models. Cartalax and Cortagen share a research category, but they are not interchangeable compounds.
New to this field? Read What Are Peptide Bioregulators? A Research Introduction.
What happens when Wave One arrives?
- Physical stock is received and checked.
- Product presentation, strength and listing information are verified.
- Images, stock status and available supporting documentation are added.
- Products are released only when their catalogue information is ready.
Arrival does not automatically mean instant availability. If an item requires further checking or information, it will remain unavailable until that work is complete.
How to follow the Wave One release
The live Coming Soon page will show the planned catalogue, while the Alpha Research Library will carry the supporting guides. Email subscribers receive priority range announcements and selected release notices without having to watch the website daily.
Researchers can also review Alpha’s approach to documentation through the Analytical Document Library. Documentation availability varies by product and batch.
Wave One FAQs
When will the new Alpha Peptides products be available?
The first shipment is expected within the coming week. Individual products will become available only after stock and catalogue checks are complete.
Can the Wave One products be pre-ordered?
No. The incoming products remain unavailable to order until Alpha has physically received and checked them.
Will every incoming product have an analytical report?
Not necessarily. Third-party analytical documentation is published where it is currently available for the relevant product or batch. Alpha does not make a universal documentation claim across products that do not yet have supporting reports.
Are the new products intended for human use?
No. Alpha Peptides supplies research materials strictly for laboratory and in vitro research purposes. They are not intended for human or veterinary consumption, diagnosis, treatment or clinical use.
Research-use notice: All products discussed in this article are intended solely for laboratory and in vitro research. Product plans, release order, availability and supporting documentation may change before launch.
